These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 386913)
1. Double-blind controlled trial with colloidal bismuth subcitrate in the treatment of symptomatic duodenal ulcers with special references to blood and urine bismuth levels. Dekker W; Reisma K Ann Clin Res; 1979 Jun; 11(3):94-7. PubMed ID: 386913 [TBL] [Abstract][Full Text] [Related]
2. Colloidal bismuth subcitrate tablets and placebo in chronic duodenal ulceration: a double-blind, randomised trial. Wilson P; Alp MH Med J Aust; 1982 Mar; 1(5):222-3. PubMed ID: 7045603 [TBL] [Abstract][Full Text] [Related]
3. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer. Vantrappen G; Schuurmans P; Rutgeerts P; Janssens J Scand J Gastroenterol Suppl; 1982; 80():23-30. PubMed ID: 6761849 [TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic duodenal ulceration. Effectiveness of colloidal bismuth subcitrate tablets compared with cimetidine. Harley H; Alp MH Med J Aust; 1983 Dec 10-24; 2(12):627-8. PubMed ID: 6366498 [TBL] [Abstract][Full Text] [Related]
5. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate. Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851 [TBL] [Abstract][Full Text] [Related]
6. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia. Vaira D; Holton J; Ainley C; Falzon M; Osborn J; D'Anna L; Romanos A; Chandrakumaran K; McNeil I Ital J Gastroenterol; 1992 Sep; 24(7):400-4. PubMed ID: 1392023 [TBL] [Abstract][Full Text] [Related]
7. Controlled trial comparing colloidal bismuth subcitrate tablets, cimetidine and placebo in the treatment of gastric ulceration. Tytgat GN; van Bentem N; van Olffen G; Dekker W; Rutgeerts L; de Boer J Scand J Gastroenterol Suppl; 1982; 80():31-8. PubMed ID: 6761850 [No Abstract] [Full Text] [Related]
8. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN; Hahm JS; Kim HJ Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924 [TBL] [Abstract][Full Text] [Related]
9. Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer. Vantrappen G; Rutgeerts P; Broeckaert L; Janssens J Gut; 1980 Apr; 21(4):329-33. PubMed ID: 7000628 [TBL] [Abstract][Full Text] [Related]
10. Pirenzepine (LS 519) in severe duodenal ulcer and in gastric ulcer. A double-blind clinical trial. Oselladore D; Chierichetti SM; Norberto L; Vibelli C Scand J Gastroenterol Suppl; 1979; 57():33-9. PubMed ID: 396655 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of colloidal bismuth (De-Nol) in the treatment of duodenal ulcer employing endoscopic selection and follow up. Salmon PR; Brown P; Williams R; Read AE Gut; 1974 Mar; 15(3):189-93. PubMed ID: 4601523 [TBL] [Abstract][Full Text] [Related]
12. A comparison of colloidal bismuth subcitrate tablets and ranitidine in the treatment of chronic duodenal ulcers. Ward M; Halliday C; Cowen AE Digestion; 1986; 34(3):173-7. PubMed ID: 3530861 [TBL] [Abstract][Full Text] [Related]
13. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers. Lane M; Lee S; Tasman-Jones C; Nicholson G N Z Med J; 1985 Mar; 98(775):191-2. PubMed ID: 3885084 [TBL] [Abstract][Full Text] [Related]
14. Comparison of qid and bd administration of De-Nol in the short term treatment of duodenal ulcer. Lazzaroni M; Petrillo M; Bianchi Porro G Br J Clin Pract; 1989 Apr; 43(4):151-5. PubMed ID: 2590626 [TBL] [Abstract][Full Text] [Related]
15. Pirenzepine in duodenal ulcer. A multicentre double-blind controlled clinical trial. Second of two parts. Barbara L; Belsasso E; Bianchi Porro G; Blasi A; Caenazzo E; Di Febo G; Di Mario F; Farini R; Giorgi-Conciato M; Mangiameli A; Miglioli M; Naccarato R; Petrillo M Scand J Gastroenterol Suppl; 1979; 57():17-9. PubMed ID: 396652 [TBL] [Abstract][Full Text] [Related]
16. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy. Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464 [TBL] [Abstract][Full Text] [Related]
17. Long-term treatment of duodenal ulcer with pirenzepine. A double-blind, placebo-controlled trial. Dal Monte PR; Bianchi Porro G; Petrillo M; Giuliani-Piccari G; D'Imperio N; Daniotti S Scand J Gastroenterol Suppl; 1982; 72():225-8. PubMed ID: 6753116 [TBL] [Abstract][Full Text] [Related]
19. Bicitropeptide powder and placebo in the treatment of duodenal ulcers. A double-blind endoscopically controlled clinical trial. Moshal MG; Spitaels JM; Bhoola R; van Leenhoff H; Khan F S Afr Med J; 1982 Feb; 61(7):234-5. PubMed ID: 7036376 [TBL] [Abstract][Full Text] [Related]
20. A double-blind study of trimipramine in the treatment of active duodenal ulceration. MacKay HP; Pickard WR; Mitchell KG; Crean GP Scand J Gastroenterol; 1984 Mar; 19(2):190-3. PubMed ID: 6372073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]